Identifying early signs of Alzheimer's disease in healthy individuals
The Emory Healthy Brain Study: Discovering Predictive Biomarkers for Alzheimer's Disease
This study is looking for early signs of Alzheimer's in healthy people aged 50-75, using tests on brain fluid and imaging, to help spot those who might be at risk in the future, and it welcomes a diverse group of participants to join in the effort to improve early detection of the disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11037899 on NIH RePORTER |
What this research studies
This research investigates how to detect early biomarkers for Alzheimer's disease in cognitively healthy individuals aged 50-75. By analyzing cerebrospinal fluid and using advanced imaging techniques, the study aims to identify individuals who may be at risk of developing Alzheimer's symptoms in the future. The research will involve regular cognitive testing and health assessments over several years, focusing on a diverse group of participants, including a significant number of African Americans. The goal is to better understand the progression of Alzheimer's and improve early detection methods.
Who could benefit from this research
Good fit: Ideal candidates for this research are cognitively healthy individuals aged 50-75, particularly those from diverse racial backgrounds, including African Americans.
Not a fit: Patients who are already diagnosed with Alzheimer's disease or exhibit significant cognitive impairment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnosis and more effective interventions for Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in using biomarkers for early detection of Alzheimer's, making this approach both relevant and potentially impactful.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Lah, James J — Emory University
- Study coordinator: Lah, James J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.